MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ALLR had -$4,180K decrease in cash & cash equivalents over the period. -$14,828K in free cash flow.

Cash Flow Overview

Change in Cash
-$4,180K
Free Cash flow
-$14,828K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from atm sales of commo...
    • Net proceeds from common stock a...
    • Unrealized foreign exchange gain
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Common stock repurchase
    • Accrued liabilities
    • Others

Cash Flow
2025-12-31
Net loss
-11,231
Depreciation and amortization
-13
Intangible asset impairment
0
Common stock issued for services
-200
Stock-based compensation expense
482
Unrealized foreign exchange gain
-1,238
Non-cash interest expense
185
Change in fair value of warrant derivative liabilities
-1
Deferred income taxes
0
Other current assets
150
Unearned revenue
0
Tax credit receivable
96
Prepaid expenses
1,603
Accounts payable
-1,139
Accrued liabilities
-2,699
Income taxes payable
7
Net cash used in operating activities
-14,820
Purchase of property and equipment
8
Net cash used in investing activities
-8
Proceeds from 3i promissory notes
0
Repayment of 3i debt
0
Proceeds from atm sales of common stock, net of issuance costs
11,143
Net proceeds from common stock and pre-funded warrant issuance
2,695
Proceeds from issuance of convertible redeemable series a preferred stock
0
Redemption of convertible redeemable series a preferred stock
0
Common stock repurchase
3,190
Net cash provided by financing activities
10,648
Net increase (decrease) in cash
-4,180
Cash, beginning of year
19,533
Cash, end of year
14,687
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from atm sales ofcommon stock, net of...$11,143K Net proceeds fromcommon stock and...$2,695K Net cash provided byfinancing activities$10,648K Canceled cashflow$3,190K Net increase(decrease) in cash-$4,180K Canceled cashflow$10,648K Unrealized foreignexchange gain-$1,238K Stock-based compensationexpense$482K Common stock issued forservices-$200K Non-cash interestexpense$185K Income taxes payable$7K Common stockrepurchase$3,190K Net cash used inoperating activities-$14,820K Canceled cashflow$2,112K Net cash used ininvesting activities-$8K Net loss-$11,231K Accrued liabilities-$2,699K Prepaid expenses$1,603K Accounts payable-$1,139K Other current assets$150K Tax creditreceivable$96K Depreciation andamortization-$13K Change in fair value ofwarrant derivative...-$1K Purchase of property andequipment$8K

Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics, Inc. (ALLR)